MiR-7-5p is frequently downregulated in glioblastoma microvasculature and inhibits vascular endothelial cell proliferation by targeting RAF1
- 444 Downloads
The aberrant expression of microRNAs (miRNAs) is always associated with tumor development and progression. Microvascular proliferation is one of the unique pathologic features of glioblastoma (GBM) . In this study, the microvasculature from GBM or normal brain tissue derived from neurosurgeries was purified and total RNA was isolated from purified microvasculature. The difference of miRNA expression profiles between glioblastoma microvasculature and normal brain capillaries was investigated. It was found that miR-7-5p in GBM microvessels was significantly reduced compared with that in normal brain capillaries. In the in vitro experiments, overexpression of miR-7-5p significantly inhibited human umbilical vein endothelial cell proliferation. Forced expression of miR-7-5p in human umbilical vein endothelial cells in vitro significantly reduced the protein level of RAF1 and repressed the activity of the luciferase, a reporter vector carrying the 3′-untranslated region of RAF1. These findings indicate that RAF1 is one of the miR-7-5p target genes. Furthermore, a significant inverse correlation between miR-7-5p expression and RAF1 protein level in GBM microvasculature was found. These data suggest that miR-7-5p functions as a tumor suppressor gene to regulate GBM microvascular endothelial cell proliferation potentially by targeting the RAF1 oncogene, implicating an important role for miR-7-5p in the pathogenesis of GBM. It may serve as a guide for the antitumor angiogenesis drug development.
KeywordsMicrovasculature MiR-7-5p Glioblastoma RAF1 Proliferation
Real-time quantitative reverse transcriptase PCR
We thank Yan Song, Meng Zhang, and Yubao Zhang for the administrative and operational support; Drs. Guiyan Xu, Guangming Qu, Deze Jia, and Donghai Wang for their helpful discussions and critical reading of the manuscript.
Ethics approval was provided by the National Hospital for Neurology and Neurosurgery Research Ethics Committee.
Conflicts of interest
None, there are no conflict of interest.
This work was supported by the National Natural Scientific Foundation of China (NO.81141088) and by the Promotive Research Fund for Excellent Young and Middle-aged Scientists of Shandong Province. (NO. 2004BS02010). JYL was supported by North Shore-LIJ Cancer Institute.
- 5.Croce CM, Calin GA. miRNAs, cancer, and stem cell division. Cell 2005; 122 (1) :6–7.Google Scholar
- 8.Van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, Wen PY, Olson JJ. Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin. 2010;60(3):166–93.Google Scholar
- 9.Kraus JA, Lamszus K, Glesmann N, Beck M, Wolter M, Sabel M, et al. Molecular genetic alterations in glioblastomas with oligodendroglial component. Acta Neuropathol. 2001;101(4):311–20.Google Scholar
- 12.Zhang C, Li C, Li J, Han J, Shang D, Zhang Y, et al. Identification of miRNA-mediated core gene module for glioma patient prediction by integrating high-throughput miRNA, mRNA expression and pathway structure. PLoS One. 2014;9(5):e96908.Google Scholar
- 14.Kefas B, Godlewski J, Comeau L, Li Y, Abounader R, Hawkinson M, Lee J, Fine H, Chiocca EA, Lawler S, Purow B. microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Cancer Res 2008; 68 (10) :3566–3572Google Scholar
- 16.Leicht DT, Balan V, Kaplun A, Singh-Gupta V, Kaplun L, Dobson M, et al. Raf kinases: function, regulation and role in human cancer. Biochim Biophys Acta. 2007;1773(8):1196–212.Google Scholar
- 17.McPhillips F, Mullen P, MacLeod KG, Sewell JM, Monia BP, Cameron DA, et al. Raf-1 is the predominant Raf isoform that mediates growth factor-stimulated growth in ovarian cancer cells. Carcinogenesis. 2006;27(4):729–39.Google Scholar
- 19.Pal A, Ahmad A, Khan S, Sakabe I, Zhang C, Kasid UN, et al. Systemic delivery of RafsiRNA using cationic cardiolipin liposomes silences Raf-1 expression and inhibits tumor growth in xenograft model of human prostate cancer. Int J Oncol. 2005;26(4):1087–91.Google Scholar
- 20.Fushimi K, Nakashima S, You F, Takigawa M, Shimizu K. Prostaglandin E2 downregulates TNF-alpha-induced production of matrix metalloproteinase-1 in HCS-2/8 chondrocytes by inhibiting Raf-1/MEK/ERK cascade through EP4 prostanoid receptor activation. J Cell Biochem. 2007;100(3):783–93.Google Scholar
- 22.von B, V, Dubben S, Engelhardt G, Hebel S, Plumakers B, Heine H, Rink L, Haase H. Zinc-dependent suppression of TNF-alpha production is mediated by protein kinase A-induced inhibition of Raf-1 , I kappa B kinase beta, and NF-kappa B. J Immunol 2007; 179 (6) :4180–4186Google Scholar
- 24.Maretzky T, Evers A, Zhou W, Swendeman SL, Wong PM, Rafii S, et al. Migration of growth factor-stimulated epithelial and endothelial cells depends on EGFR transactivation by ADAM17. Nat Commun. 2011;2:229.Google Scholar
- 25.Kyriakakis E, Cavallari M, Pfaff D, Fabbro D, Mestan J, Philippova M, et al. IL-8-mediated angiogenic responses of endothelial cells to lipid antigen activation of iNKT cells depend on EGFR transactivation. J Leukoc Biol. 2011;90(5):929–39.Google Scholar
- 26.Guang-Wu H, Sunagawa M, Jie-En L, Shimada S, Gang Z, Tokeshi Y, et al. The relationship between microvessel density, the expression of vascular endothelial growth factor (VEGF), and the extension of nasopharyngeal carcinoma. Laryngoscope. 2000;110(12):2066–9.Google Scholar
- 29.Chiplunkar AR, Curtis BC, Eades GL, Kane MS, Fox SJ, Haar JL, et al. The Kruppel-like factor 2 and Kruppel-like factor 4 genes interact to maintain endothelial integrity in mouse embryonic vasculogenesis. BMC Dev Biol. 2013;13:40.Google Scholar
- 31.Lee JW, Soung YH, Kim SY, Nam SW, Park WS, Lee JY, et al. Absence of JAK2 V617F mutation in gastric cancers. Acta Oncol. 2006;45(2):222–3.Google Scholar